vs
AVANOS MEDICAL, INC.（AVNS）とJ&J SNACK FOODS CORP（JJSF）の財務データ比較。上の社名をクリックして会社を切り替えられます
J&J SNACK FOODS CORPの直近四半期売上が大きい（$343.8M vs $180.9M、AVANOS MEDICAL, INC.の約1.9倍）。J&J SNACK FOODS CORPの純利益率が高く（0.3% vs -0.7%、差は1.0%）。AVANOS MEDICAL, INC.の前年同期比売上増加率が高い（0.7% vs -5.2%）。AVANOS MEDICAL, INC.の直近四半期フリーキャッシュフローが多い（$21.3M vs $17.0M）。過去8四半期でAVANOS MEDICAL, INC.の売上複合成長率が高い（4.4% vs -2.2%）
Avanos Medicalは医療テクノロジー企業で、臨床医療機器の開発・製造に注力しており、疼痛管理と慢性ケアの2つのコア事業を展開しています。患者の回復促進や感染予防に取り組みながら、治療におけるオピオイド系薬剤の使用削減を目指しています。
J&Jスナックフーズ社は米国の有名なブランドスナック菓子・冷凍飲料の製造・販売・流通業者で、本社はニュージャージー州マウントローレルに所在します。米国44州、メキシコ、カナダに175を超える生産・保管・流通拠点を構え、ナスダックグローバルセレクト市場に上場し、国内外の市場に事業を展開しています。
AVNS vs JJSF — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $180.9M | $343.8M |
| 純利益 | $-1.3M | $883.0K |
| 粗利率 | 47.5% | 27.9% |
| 営業利益率 | 1.4% | 0.2% |
| 純利益率 | -0.7% | 0.3% |
| 売上前年比 | 0.7% | -5.2% |
| 純利益前年比 | 99.7% | -82.8% |
| EPS（希薄化後） | $-0.02 | $0.05 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $180.9M | $343.8M | ||
| Q3 25 | $177.8M | $410.2M | ||
| Q2 25 | $175.0M | $454.3M | ||
| Q1 25 | $167.5M | $356.1M | ||
| Q4 24 | $179.6M | $362.6M | ||
| Q3 24 | $170.4M | $426.8M | ||
| Q2 24 | $171.7M | $440.0M | ||
| Q1 24 | $166.1M | $359.7M |
| Q4 25 | $-1.3M | $883.0K | ||
| Q3 25 | $-1.4M | $11.4M | ||
| Q2 25 | $-76.8M | $44.2M | ||
| Q1 25 | $6.6M | $4.8M | ||
| Q4 24 | $-397.3M | $5.1M | ||
| Q3 24 | $4.3M | $29.6M | ||
| Q2 24 | $1.8M | $36.3M | ||
| Q1 24 | $-900.0K | $13.3M |
| Q4 25 | 47.5% | 27.9% | ||
| Q3 25 | 48.4% | 31.7% | ||
| Q2 25 | 52.6% | 33.0% | ||
| Q1 25 | 53.6% | 26.9% | ||
| Q4 24 | 54.6% | 25.9% | ||
| Q3 24 | 54.5% | 31.8% | ||
| Q2 24 | 55.7% | 33.6% | ||
| Q1 24 | 57.1% | 30.1% |
| Q4 25 | 1.4% | 0.2% | ||
| Q3 25 | 0.1% | 2.8% | ||
| Q2 25 | -42.6% | 13.3% | ||
| Q1 25 | 6.1% | 1.7% | ||
| Q4 24 | -233.0% | 1.7% | ||
| Q3 24 | 7.0% | 9.3% | ||
| Q2 24 | 3.7% | 11.4% | ||
| Q1 24 | 2.4% | 5.0% |
| Q4 25 | -0.7% | 0.3% | ||
| Q3 25 | -0.8% | 2.8% | ||
| Q2 25 | -43.9% | 9.7% | ||
| Q1 25 | 3.9% | 1.4% | ||
| Q4 24 | -221.2% | 1.4% | ||
| Q3 24 | 2.5% | 6.9% | ||
| Q2 24 | 1.0% | 8.3% | ||
| Q1 24 | -0.5% | 3.7% |
| Q4 25 | $-0.02 | $0.05 | ||
| Q3 25 | $-0.03 | $0.59 | ||
| Q2 25 | $-1.66 | $2.26 | ||
| Q1 25 | $0.14 | $0.25 | ||
| Q4 24 | $-8.64 | $0.26 | ||
| Q3 24 | $0.09 | $1.52 | ||
| Q2 24 | $0.04 | $1.87 | ||
| Q1 24 | $-0.02 | $0.69 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $89.8M | $66.8M |
| 総負債低いほど良い | $90.3M | — |
| 株主資本純資産 | $778.2M | $912.9M |
| 総資産 | $1.1B | $1.3B |
| 負債/資本比率低いほどレバレッジが低い | 0.12× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $89.8M | $66.8M | ||
| Q3 25 | $70.5M | $105.9M | ||
| Q2 25 | $90.3M | $77.4M | ||
| Q1 25 | $97.0M | $48.5M | ||
| Q4 24 | $107.7M | $73.6M | ||
| Q3 24 | $89.0M | $73.4M | ||
| Q2 24 | $92.2M | $64.0M | ||
| Q1 24 | $75.8M | $43.6M |
| Q4 25 | $90.3M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | — | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — | ||
| Q1 24 | $167.2M | — |
| Q4 25 | $778.2M | $912.9M | ||
| Q3 25 | $778.0M | $966.7M | ||
| Q2 25 | $776.3M | $969.9M | ||
| Q1 25 | $839.4M | $935.0M | ||
| Q4 24 | $828.5M | $946.8M | ||
| Q3 24 | $1.2B | $957.0M | ||
| Q2 24 | $1.2B | $937.9M | ||
| Q1 24 | $1.2B | $915.7M |
| Q4 25 | $1.1B | $1.3B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.0B | $1.4B | ||
| Q1 25 | $1.1B | $1.4B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $1.7B | $1.4B | ||
| Q2 24 | $1.7B | $1.4B | ||
| Q1 24 | $1.7B | $1.3B |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $28.2M | $36.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $21.3M | $17.0M |
| FCFマージンFCF / 売上 | 11.8% | 4.9% |
| 設備投資強度設備投資 / 売上 | 3.8% | 5.5% |
| キャッシュ転換率営業CF / 純利益 | — | 40.73× |
| 直近12ヶ月FCF直近4四半期 | $43.1M | $83.1M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $28.2M | $36.0M | ||
| Q3 25 | $14.0M | $66.4M | ||
| Q2 25 | $6.8M | $51.2M | ||
| Q1 25 | $25.7M | $12.3M | ||
| Q4 24 | $57.9M | $35.2M | ||
| Q3 24 | $23.0M | $46.3M | ||
| Q2 24 | $27.8M | $65.0M | ||
| Q1 24 | $-8.0M | $12.7M |
| Q4 25 | $21.3M | $17.0M | ||
| Q3 25 | $7.0M | $44.8M | ||
| Q2 25 | $-4.2M | $28.5M | ||
| Q1 25 | $19.0M | $-7.2M | ||
| Q4 24 | $53.1M | $16.1M | ||
| Q3 24 | $20.0M | $29.1M | ||
| Q2 24 | $21.9M | $45.3M | ||
| Q1 24 | $-12.1M | $-4.0M |
| Q4 25 | 11.8% | 4.9% | ||
| Q3 25 | 3.9% | 10.9% | ||
| Q2 25 | -2.4% | 6.3% | ||
| Q1 25 | 11.3% | -2.0% | ||
| Q4 24 | 29.6% | 4.4% | ||
| Q3 24 | 11.7% | 6.8% | ||
| Q2 24 | 12.8% | 10.3% | ||
| Q1 24 | -7.3% | -1.1% |
| Q4 25 | 3.8% | 5.5% | ||
| Q3 25 | 3.9% | 5.3% | ||
| Q2 25 | 6.3% | 5.0% | ||
| Q1 25 | 4.0% | 5.5% | ||
| Q4 24 | 2.7% | 5.3% | ||
| Q3 24 | 1.8% | 4.0% | ||
| Q2 24 | 3.4% | 4.5% | ||
| Q1 24 | 2.5% | 4.6% |
| Q4 25 | — | 40.73× | ||
| Q3 25 | — | 5.84× | ||
| Q2 25 | — | 1.16× | ||
| Q1 25 | 3.89× | 2.55× | ||
| Q4 24 | — | 6.84× | ||
| Q3 24 | 5.35× | 1.56× | ||
| Q2 24 | 15.44× | 1.79× | ||
| Q1 24 | — | 0.96× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
JJSF
| Food Service | $219.2M | 64% |
| Frozen Beverages | $78.7M | 23% |
| Repair And Maintenance Service | $22.5M | 7% |
| Other | $12.7M | 4% |
| Machine Sales | $10.7M | 3% |
